Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 216

1.
2.

Risks and benefits of oral anticoagulation compared with clopidogrel plus aspirin in patients with atrial fibrillation according to stroke risk: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE-W).

Healey JS, Hart RG, Pogue J, Pfeffer MA, Hohnloser SH, De Caterina R, Flaker G, Yusuf S, Connolly SJ.

Stroke. 2008 May;39(5):1482-6. doi: 10.1161/STROKEAHA.107.500199. Epub 2008 Mar 6.

3.

Warfarin is not needed in low-risk patients following atrial fibrillation ablation procedures.

Bunch TJ, Crandall BG, Weiss JP, May HT, Bair TL, Osborn JS, Anderson JL, Lappe DL, Muhlestein JB, Nelson J, Allison S, Foley T, Anderson L, Day JD.

J Cardiovasc Electrophysiol. 2009 Sep;20(9):988-93. doi: 10.1111/j.1540-8167.2009.01481.x. Epub 2009 May 15.

PMID:
19473299
4.
5.

Protocol for Birmingham Atrial Fibrillation Treatment of the Aged study (BAFTA): a randomised controlled trial of warfarin versus aspirin for stroke prevention in the management of atrial fibrillation in an elderly primary care population [ISRCTN89345269].

Mant JW, Richards SH, Hobbs FD, Fitzmaurice D, Lip GY, Murray E, Banting M, Fletcher K, Rahman J, Allan T, Raftery J, Bryan S; Midlands Research Consortium of General Practice.

BMC Cardiovasc Disord. 2003 Aug 26;3:9. Epub 2003 Aug 26.

7.
8.

Fecal hemoglobin excretion in elderly patients with atrial fibrillation: combined aspirin and low-dose warfarin vs conventional warfarin therapy.

Blackshear JL, Baker VS, Holland A, Litin SC, Ahlquist DA, Hart RG, Ellefson R, Koehler J.

Arch Intern Med. 1996 Mar 25;156(6):658-60.

PMID:
8629878
9.

Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.

Flaker GC, Gruber M, Connolly SJ, Goldman S, Chaparro S, Vahanian A, Halinen MO, Horrow J, Halperin JL; SPORTIF Investigators.

Am Heart J. 2006 Nov;152(5):967-73.

PMID:
17070169
10.
11.

Effect of fixed low-dose warfarin added to aspirin in the long term after acute myocardial infarction; the LoWASA Study.

Herlitz J, Holm J, Peterson M, Karlson BW, Haglid Evander M, Erhardt L; LoWASA study group.

Eur Heart J. 2004 Feb;25(3):232-9.

12.
13.

Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.

DiMarco JP, Flaker G, Waldo AL, Corley SD, Greene HL, Safford RE, Rosenfeld LE, Mitrani G, Nemeth M; AFFIRM Investigators.

Am Heart J. 2005 Apr;149(4):650-6.

PMID:
15990748
14.

Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy.

Hohnloser SH, Pajitnev D, Pogue J, Healey JS, Pfeffer MA, Yusuf S, Connolly SJ; ACTIVE W Investigators.

J Am Coll Cardiol. 2007 Nov 27;50(22):2156-61. Epub 2007 Nov 13.

15.

Gender differences in stroke risk of atrial fibrillation patients on oral anticoagulant treatment.

Poli D, Antonucci E, Grifoni E, Abbate R, Gensini GF, Prisco D.

Thromb Haemost. 2009 May;101(5):938-42.

PMID:
19404548
16.

Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.

Jacobs LG, Billett HH, Freeman K, Dinglas C, Jumaquio L.

Am J Geriatr Pharmacother. 2009 Jun;7(3):159-66. doi: 10.1016/j.amjopharm.2009.06.002.

PMID:
19616184
17.

Efficacy of anticoagulation for secondary stroke prevention in older people with non-valvular atrial fibrillation: a prospective case series study.

Tsivgoulis G, Spengos K, Zakopoulos N, Manios E, Peppes V, Vemmos K.

Age Ageing. 2005 Jan;34(1):35-40.

18.

Warfarin in atrial fibrillation patients with moderate chronic kidney disease.

Hart RG, Pearce LA, Asinger RW, Herzog CA.

Clin J Am Soc Nephrol. 2011 Nov;6(11):2599-604. doi: 10.2215/CJN.02400311. Epub 2011 Sep 8.

19.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk